JESSICA RECKART: Open Payments
NPI 1710417050 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 58 payments from 17 companies in 2025. Trend: 2023 $819 · 2024 $1,188 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $326 |
| Novo Nordisk Inc | 12 | $201 |
| PFIZER INC. | 12 | $160 |
| GlaxoSmithKline, LLC. | 5 | $93 |
| Merck Sharp & Dohme LLC | 4 | $79 |
| Abbott Laboratories | 3 | $56 |
| ABBVIE INC. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Lilly USA, LLC | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: FARXIGA, BREZTRI, GARDASIL 9, ELIQUIS, TRELEGY ELLIPTA, Wegovy, NURTEC ODT, XIFAXAN.
Industry payments across PA — which companies pay providers there.
